naltrexone and Fatty Liver, Nonalcoholic

naltrexone has been researched along with Fatty Liver, Nonalcoholic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Bajaj, HS; Barakat, M; Blavignac, J; Burrows, M; Camacho, F; Gould, E; Paron, E	1
Dehpou, AR; Dehpour, AR; Hassanzadeh, G; Moslehi, A; Nabavizadeh, F; Nahrevanian, H; Sohanaki, H; Tavanga, SM; Zekri, A	1

Other Studies

2 other study(ies) available for naltrexone and Fatty Liver, Nonalcoholic

Article	Year
Extended-release naltrexone/bupropion and liver health: Pooled, post hoc analysis from four randomized controlled trials. Diabetes, obesity & metabolism, 2021, Volume: 23, Issue:3 Topics: Adult; Alanine Transaminase; Bupropion; Double-Blind Method; Female; Humans; Liver; Male; Naltrexone; Non-alcoholic Fatty Liver Disease; Randomized Controlled Trials as Topic	2021
Naltrexone attenuates endoplasmic reticulum stress induced hepatic injury in mice. Acta physiologica Hungarica, 2014, Volume: 101, Issue:3 Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; bcl-2-Associated X Protein; Biomarkers; Caspase 3; Chemical and Drug Induced Liver Injury; Cholesterol; Cytoprotection; Disease Models, Animal; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Fatty Liver; Liver; Liver Circulation; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Non-alcoholic Fatty Liver Disease; Proto-Oncogene Proteins c-bcl-2; Triglycerides; Tumor Necrosis Factor-alpha; Tunicamycin	2014

Article

Year

Extended-release naltrexone/bupropion and liver health: Pooled, post hoc analysis from four randomized controlled trials.

Diabetes, obesity & metabolism, 2021, Volume: 23, Issue:3

Topics: Adult; Alanine Transaminase; Bupropion; Double-Blind Method; Female; Humans; Liver; Male; Naltrexone; Non-alcoholic Fatty Liver Disease; Randomized Controlled Trials as Topic

2021

Naltrexone attenuates endoplasmic reticulum stress induced hepatic injury in mice.

Acta physiologica Hungarica, 2014, Volume: 101, Issue:3

Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; bcl-2-Associated X Protein; Biomarkers; Caspase 3; Chemical and Drug Induced Liver Injury; Cholesterol; Cytoprotection; Disease Models, Animal; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Fatty Liver; Liver; Liver Circulation; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Non-alcoholic Fatty Liver Disease; Proto-Oncogene Proteins c-bcl-2; Triglycerides; Tumor Necrosis Factor-alpha; Tunicamycin

2014